Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia

Adrenomedullin (ADM) is a hypotensive and vasodilator peptide belonging to the calcitonin gene-related peptide family. It is secreted in vitro by endothelial cells and vascular smooth muscle cells, and is significantly upregulated by a number of stimuli. Moreover, ADM participates in the regulation of hematopoietic compartment, solid tumors and leukemias, such as acute myeloid leukemia (AML). To better characterize ADM involvement in AML pathogenesis, we investigated its expression during human hematopoiesis and in leukemic subsets, based on a morphological, cytogenetic and molecular characterization and in T cells from AML patients. In hematopoietic stem/progenitor cells and T lymphocytes from healthy subjects, ADM transcript was barely detectable. It was expressed at low levels by megakaryocytes and erythroblasts, while higher levels were measured in neutrophils, monocytes and plasma cells. Moreover, cells populating the hematopoietic niche, including mesenchymal stem cells, showed to express ADM. ADM was overexpressed in AML cells versus normal CD34+ cells and in the subset of leukemia compared with hematopoietic stem cells. In parallel, we detected a significant variation of ADM expression among cytogenetic subgroups, measuring the highest levels in inv(16)/t(16;16) or complex karyotype AML. According to the mutational status of AML-related genes, the analysis showed a lower expression of ADM in FLT3-ITD, NPM1-mutated AML and FLT3-ITD/NPM1-mutated cases compared with wild-type ones. Moreover, ADM expression had a negative impact on overall survival within the favorable risk class, while showing a potential positive impact within the subgroup receiving a not-intensive treatment. The expression of 135 genes involved in leukemogenesis, regulation of cell proliferation, ferroptosis, protection from apoptosis, HIF-1α signaling, JAK-STAT pathway, immune and inflammatory responses was correlated with ADM levels in the bone marrow cells of at least two AML cohorts. Moreover, ADM was upregulated in CD4+ T and CD8+ T cells from AML patients compared with healthy controls and some ADM co-expressed genes participate in a signature of immune tolerance that characterizes CD4+ T cells from leukemic patients. Overall, our study shows that ADM expression in AML associates with a stem cell phenotype, inflammatory signatures and genes related to immunosuppression, all factors that contribute to therapy resistance and disease relapse.

[1]  J. Tamburini,et al.  Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells , 2020, Nature Communications.

[2]  D. Bottomly,et al.  Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia , 2020, Nature Cancer.

[3]  F. Di Virgilio,et al.  Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells , 2020, Frontiers in Oncology.

[4]  K. Shima,et al.  Annexin V expression on CD4+ T cells with regulatory function , 2019, Immunology.

[5]  Q. Lu,et al.  TSLP epigenetically upregulates FcRγ-related receptors on APCs and induces TH2/TH17 polarization via dectin-2. , 2019, The Journal of allergy and clinical immunology.

[6]  S. Endo,et al.  JunB plays a crucial role in development of regulatory T cells by promoting IL-2 signaling , 2019, Mucosal Immunology.

[7]  Johannes L. Schönberger,et al.  SciPy 1.0: fundamental algorithms for scientific computing in Python , 2019, Nature Methods.

[8]  W. Hiddemann,et al.  The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia , 2019, Leukemia.

[9]  J. Maciejewski,et al.  A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia , 2019, Clinical Cancer Research.

[10]  C. Simillion,et al.  CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia , 2019, Leukemia.

[11]  Tamara J. Blätte,et al.  Deregulated expression of circular RNAs in acute myeloid leukemia. , 2018, Blood advances.

[12]  G. Boucher,et al.  Genetic characterization of ABT-199 sensitivity in human AML , 2018, Leukemia.

[13]  G. Castellani,et al.  Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery , 2018, Cancer.

[14]  Beth Wilmot,et al.  Functional Genomic Landscape of Acute Myeloid Leukemia , 2018, Nature.

[15]  H. Snoeck,et al.  PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature , 2018, The Journal of clinical investigation.

[16]  A. Schambach,et al.  The non-coding RNA landscape of human hematopoiesis and leukemia , 2017, Nature Communications.

[17]  A. Beck‐Sickinger,et al.  Adrenomedullin – new perspectives of a potent peptide hormone , 2017, Journal of peptide science : an official publication of the European Peptide Society.

[18]  P. Pandolfi,et al.  Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling. , 2017, Cancer research.

[19]  M. O. Baratti,et al.  Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[20]  Steven J. M. Jones,et al.  The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery , 2016, Cell.

[21]  W. Gu,et al.  Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses , 2016, Proceedings of the National Academy of Sciences.

[22]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[23]  C. Grandi,et al.  Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells. , 2016, International journal of oncology.

[24]  Andrew P. Feinberg,et al.  An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis , 2015, Nature Communications.

[25]  M. Merad,et al.  CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation , 2015, Nature Immunology.

[26]  A. Yoshimura,et al.  Control of IFN‐γ production and regulatory function by the inducible nuclear protein IκB‐ζ in T cells , 2015, Journal of leukocyte biology.

[27]  Alfredo Martínez,et al.  Adrenomedullin and tumour microenvironment , 2014, Journal of Translational Medicine.

[28]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[29]  G. Robledo,et al.  Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels , 2014, Brain, Behavior, and Immunity.

[30]  Shun-Fa Yang,et al.  Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2. , 2014, Biochimica et biophysica acta.

[31]  Harald Binder,et al.  Transforming RNA-Seq Data to Improve the Performance of Prognostic Gene Signatures , 2014, PloS one.

[32]  Cedric E. Dos Santos,et al.  The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents. , 2013, Blood.

[33]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[34]  R. Jha,et al.  Elevated expression of adrenomedullin is correlated with prognosis and disease severity in osteosarcoma , 2013, Medical Oncology.

[35]  K. Kitamura,et al.  Adrenomedullin: a novel therapy for intractable ulcerative colitis. , 2013, Inflammatory bowel diseases.

[36]  L. Rönnstrand,et al.  Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling , 2012, PloS one.

[37]  F. Lioté,et al.  Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi‐mature tolerogenic dendritic cells , 2012, Immunology.

[38]  Yasutaka Tanaka,et al.  Transcriptional Repression of Cdc25B by IER5 Inhibits the Proliferation of Leukemic Progenitor Cells through NF-YB and p300 in Acute Myeloid Leukemia , 2011, PloS one.

[39]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[40]  Kihyun Lee,et al.  Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells , 2011, Proceedings of the National Academy of Sciences.

[41]  K. Mimori,et al.  Hypoxia-inducible adrenomedullin in colorectal cancer. , 2011, Anticancer research.

[42]  N. Friedman,et al.  Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis , 2011, Cell.

[43]  Ash A. Alizadeh,et al.  Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. , 2010, JAMA.

[44]  Pedro M. Valero-Mora,et al.  ggplot2: Elegant Graphics for Data Analysis , 2010 .

[45]  S. Salas,et al.  Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear‐cell renal carcinoma , 2009, International journal of cancer.

[46]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[47]  J. Gribben,et al.  Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. , 2009, Blood.

[48]  Bas J. Wouters,et al.  Brief Report Results and Discussion , 2022 .

[49]  Bas J. Wouters,et al.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling , 2009, Haematologica.

[50]  G. Gwak,et al.  Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth. , 2008, Cancer letters.

[51]  Torsten Haferlach,et al.  An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase , 2008, British journal of haematology.

[52]  S. Kawasaki,et al.  Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis? , 2008, Hepato-gastroenterology.

[53]  B. Uzan,et al.  Adrenomedullin is anti‐apoptotic in osteoblasts through CGRP1 receptors and MEK‐ERK pathway , 2008, Journal of cellular physiology.

[54]  C. Récher,et al.  A critical role for Lyn in acute myeloid leukemia. , 2008, Blood.

[55]  J. Launay,et al.  A Critical Role for Adrenomedullin-Calcitonin Receptor-Like Receptor in Regulating Rheumatoid Fibroblast-Like Synoviocyte Apoptosis1 , 2006, The Journal of Immunology.

[56]  H. Dressman,et al.  Molecular Profile and Partial Functional Analysis of Novel Endothelial Cell‐Derived Growth Factors that Regulate Hematopoiesis , 2006, Stem cells.

[57]  P. W. Grosvenor,et al.  Mechanisms of adrenomedullin antimicrobial action , 2006, Peptides.

[58]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Conconi,et al.  Adrenomedullin and endothelin-1 stimulate in vitro expansion of cord blood hematopoietic stem cells. , 2004, International Journal of Molecular Medicine.

[60]  Y. Okada,et al.  Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells 1 , 2003, The Journal of Immunology.

[61]  Ping Wang,et al.  Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-α in macrophage cell line and rat Kupffer cells , 2003, Regulatory Peptides.

[62]  K. Nakao,et al.  Adrenomedullin promotes proliferation and migration of cultured endothelial cells. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[63]  P. Parnigotto,et al.  Adrenomedullin is expressed in cord blood hematopoietic cells and stimulates their clonal growth. , 2003, International journal of molecular medicine.

[64]  N. Brünner,et al.  Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. , 2002, The American journal of pathology.

[65]  K. Kario,et al.  Interaction between monocytes and vascular endothelial cells induces adrenomedullin production. , 2001, Atherosclerosis.

[66]  L. Ouafik,et al.  Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. , 2001, Cancer research.

[67]  K. Takahashi,et al.  Transcriptional control of adrenomedullin induction by phorbol ester in human monocytic leukemia cells. , 2000, European journal of biochemistry.

[68]  D. Smith,et al.  Adrenomedullin, a multifunctional regulatory peptide. , 2000, Endocrine reviews.

[69]  K. Takahashi,et al.  Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis. , 1999, Clinical science.

[70]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[71]  N. Minamino,et al.  Adrenomedullin production is correlated with differentiation in human leukemia cell lines and peripheral blood monocytes , 1998, FEBS letters.

[72]  M. Kodama,et al.  Adrenomedullin promotes the epithelial restitution of rat and human gastric mucosa in vitro , 1998 .

[73]  N. Minamino,et al.  Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. , 1995, Biochemical and biophysical research communications.

[74]  T. Ishimitsu,et al.  Genomic structure of human adrenomedullin gene. , 1994, Biochemical and biophysical research communications.

[75]  K. Kangawa,et al.  Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. , 1993, Biochemical and biophysical research communications.

[76]  K. Kangawa,et al.  Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. , 1993, Biochemical and biophysical research communications.

[77]  Q. Lu,et al.  TSLP epigenetically upregulates FcRγ-related receptors on APCs and induces TH2/TH17 polarization via dectin-2. , 2019, The Journal of allergy and clinical immunology.

[78]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[79]  A. Chorny,et al.  Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells. , 2007, The American journal of pathology.

[80]  I. Mackenzie,et al.  Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium , 2022 .